Skip to main content
BL Pharmtech Corp. logo

BL Pharmtech Corp. — Investor Relations & Filings

Ticker · 065170 ISIN · KR7065170003 KO Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 065170

About BL Pharmtech Corp.

http://www.blpharmtech.com/

BL Pharmtech Corp. is a healthcare company that manufactures, distributes, and sells health functional foods, dietary supplements, and nutraceuticals. The company's portfolio also includes cosmetics, food additives, and pharmaceuticals. A significant part of its operations is dedicated to biotechnology and bio-pharmaceutical research and development. Through its Daedeok Research Institute and in collaboration with subsidiaries BL Melanys and BL Science, the company partners with academic institutions, including KAIST and Columbia University Medical Center, to advance its research initiatives.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 87% confidence The document is titled “분기보고서” covering the period 2026-01-01 to 2026-03-31 (32nd fiscal period, Q1). It contains detailed financial statements, segment revenues, risk management disclosures, asset schedules, and extensive narrative of business operations—hallmarks of a full interim/quarterly report, not just an announcement or summary. Therefore, it fits the Interim/Quarterly Report category. Q1 2026
2026-05-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a formal regulatory notice reporting the appointment (and related changes) of an outside director at a listed company. It details changes to the board of directors (사외이사의 신규선임), including names, dates, and terms. Such filings are classified under Board/Management Information.
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document provides detailed results of an Annual General Meeting (정기주주총회결과), including approvals of financial statements, dividend resolutions, election of directors and auditors, and vote tallies with percentages for each agenda item. This corresponds exactly to a Declaration of Voting Results & Voting Rights Announcement rather than the report itself or a solicitation. Therefore, it should be classified as DVA.
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 31st fiscal year (2025) of BL Pharmtech Corp. It contains detailed company information, business operations, financial data, and management discussions. This is the standard Korean regulatory filing equivalent to an Annual Report (10-K). FY 2025
2026-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 92% confidence The document is titled “감사보고서 제출” (Audit Report Submission) and includes detailed audit opinions for both consolidated and separate financial statements, showing unqualified opinions, key balance sheet and income statement figures, audit firm name, and submission date. This is not merely a brief notice of report publication but contains substantive audit report information. It matches the definition of a standalone Audit Report (AR). FY 2025
2026-03-23 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a “주식등의 대량보유상황보고서(약식)” (Report on Major Shareholding Positions) filed by a substantial shareholder under Korean capital markets law. It details the number of shares and voting rights held, changes in holdings, and the purpose of holdings by the reporting investor and related parties. This aligns exactly with a Major Shareholding Notification (MRQ) rather than an earnings release, annual report, or insider dealing report.
2026-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.